Similar Papers

Paper Title
Journal
Date
Author
Biomarkers of response in patients with gastric/gastroesophageal junction adenocarcinoma (GEA) treated with telisotuzumab adizutecan.
John H Strickler ... Yasutoshi Kuboki
Journal of Clinical Oncology | VOL. 43
John H Strickler, et. al.John H Strickler ... Yasutoshi Kuboki
01 Feb 2025
A Novel Antibody Drug Conjugate (ADC) Targeting Cell Surface Heat Shock Protein 70 (csHSP70) Is Active Against Pre-Clinical Models of Peripheral T-Cell Lymphoma (PTCL)
Rajan Kumar Choudhary ... Robert Z Orlowski
Blood | VOL. 138
Rajan Kumar Choudhary, et. al.Rajan Kumar Choudhary ... Robert Z Orlowski
05 Nov 2021
Abstract 6174: Developing a novel antibody drug conjugate against cervical cancer
Shili Yao ... Bing Zhu
Cancer Research | VOL. 82
Shili Yao, et. al.Shili Yao ... Bing Zhu
15 Jun 2022
Abstract 4689: 4HF CancerDataMiner platform accelerates target discovery and evaluation
Heinz-Herbert Fiebig ... Anne-Lise Peille
Cancer Research | VOL. 84
Heinz-Herbert Fiebig, et. al.Heinz-Herbert Fiebig ... Anne-Lise Peille
22 Mar 2024
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors
J.M Riedl ... R.B Corcoran
Annals of Oncology | VOL. -
J.M Riedl, et. al.J.M Riedl ... R.B Corcoran
01 Feb 2025
Whole genome sequencing powered ctDNA sequencing for breast cancer detection
I Garcia-Murillas ... N.C Turner
Annals of Oncology | VOL. -
I Garcia-Murillas, et. al.I Garcia-Murillas ... N.C Turner
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.